We are live on
!
Find out more
RM
RP Management Portfolio holdings
AUM
$139M
1-Year Est. Return
37.98%
This Fund
S&P 500
This Quarter
Est. Return
-35.19%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$283M
AUM Growth
-$97.5M
(-26%)
Cap. Flow
+$53.7M
Cap. Flow
% of AUM
18.95%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
EPZM
Epizyme, Inc
EPZM
|
+$53.7M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 79.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
1
DELISTED
Epizyme, Inc
EPZM
| $142M | 50.18% |
9,166,667
+2,500,000
| +37% | +$53.7M |
|
|
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $71.8M | 25.35% |
2,111,111
| – | – |
|
|
IMMU
3
DELISTED
Immunomedics Inc
IMMU
| $59M | 20.81% |
4,373,178
| – | – |
|
4
Cytokinetics
CYTK
$11.5B
| $10.3M | 3.64% |
875,656
| – | – |
|
|
VIRX
5
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $53K | 0.02% |
3,700
| – | – |
|
Similar funds
PC
LA
TP
SC
MFG
MADFP
RM
NC